Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Sep 15, 2021; 13(9): 995-1016
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.995
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.995
Table 5 Enrichment analysis of the target genes of the altered microRNAs in inflammatory bowel disease-associated colorectal cancer
| Pathway | P value | Adjusted P value |
| VEGFA-VEGFR2 signaling pathway | 2.577e-31 | 1.203e-28 |
| TGF-beta signaling pathway | 1.823e-23 | 4.257e-21 |
| EGF/EGFR signaling pathway | 6.399e-20 | 9.961e-18 |
| DNA damage response (only ATM dependent) | 8.953e-20 | 1.045e-17 |
| Oncostatin M signaling pathway | 1.426e-18 | 1.322e-16 |
| Integrated breast cancer pathway | 1.699e-18 | 1.322e-16 |
| Insulin signaling | 4.429e-18 | 2.955e-16 |
| Focal adhesion | 2.120e-17 | 1.238e-15 |
| Signaling pathways in glioblastoma | 4.047e-17 | 2.100e-15 |
| ErbB signaling pathway | 4.559e-16 | 2.129e-14 |
- Citation: Grillo TG, Quaglio AEV, Beraldo RF, Lima TB, Baima JP, Di Stasi LC, Sassaki LY. MicroRNA expression in inflammatory bowel disease-associated colorectal cancer. World J Gastrointest Oncol 2021; 13(9): 995-1016
- URL: https://www.wjgnet.com/1948-5204/full/v13/i9/995.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i9.995